SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Medtox (TOX) = Editek's new name/thread = cheap

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  
To: KonKilo who wrote (23)6/20/1998 12:10:00 PM
From: David Haith   of 24
 
This was posted on Yahoo

Hello

I just called Schwab and they confirmed the Buyout offer from Morgan Capital at .50.
There are three news releases concerning this on the DowJones service.

The management of TOX has not responded to the offer, as yet. The press release said that Morgan has spent money on the due diligence and wants to meet with the TOX board this week.

It is true.
Good work BYeager!!

Morgan sees the potential in the Profiler II product and in this company.
Monday should be an interesting trading day!!
Will TOX agree with Morgan's offer?.
With the shareholders (many who purchased above .50) agree to this takeover?.
Will all the news and publicity generate interest from investors if the deal is not approved?.
Will other companies attempt to make an offer for TOX?

We will see!!

Bar
ÿ
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext